|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/519 | (2006.01) |
| A61P 35/00 | (2006.01) | ||
| A61P 35/04 | (2006.01) |
| (11) | Number of the document | 4340842 |
| (13) | Kind of document | T |
| (96) | European patent application number | 22729925.2 |
| Date of filing the European patent application | 2022-05-17 | |
| (97) | Date of publication of the European application | 2024-03-27 |
| (45) | Date of publication and mention of the grant of the patent | 2025-08-27 |
| (46) | Date of publication of the claims translation | 2025-11-25 |
| (86) | Number | PCT/US2022/029677 |
| Date | 2022-05-17 |
| (87) | Number | WO 2022/245857 |
| Date | 2022-11-24 |
| (30) | Number | Date | Country code |
| 202163190061 P | 2021-05-18 | US |
| (72) |
HENARY, Haby , US
NGARMCHAMNANRITH, Gataree , US
PARK, Joseph , US
DUTTA, Sandeep , US
FRIBERG, Gregory , US
HOUK, Brett E. , US
MATHER, Omar , US
|
| (73) |
Amgen Inc. ,
One Amgen Center Drive, Thousand Oaks, California 91320,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Sotorasibas, skirtas naudoti vėžio gydymui |
| SOTORASIB FOR USE IN THE TREATMENT OF CANCER |